Reduced RAC1 activity inhibits cell proliferation and induces apoptosis in neurofibromatosis type 2(NF2)-associated schwannoma

References

• Asthagiri AR, Parry DM, Butman JA, et al. Neurofibromatosis type 2. Lancet. 2009;373:1974–1986 . Epub 2009/05/30.10.1016/S0140-6736(09)60259-2
   PubMed Web of Science ®Google Scholar
• Lim SH, Ardern-Holmes S, McCowage G, et al. Systemic therapy in neurofibromatosis type 2. Cancer Treatment Rev. 2014;40:857–861. Epub 2014/06/01.10.1016/j.ctrv.2014.05.004
   PubMed Web of Science ®Google Scholar
• Dewan R, Pemov A, Kim HJ, et al. Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas. Neuro-Oncology. 2015;17:566–573.10.1093/neuonc/nou317
   PubMed Web of Science ®Google Scholar
• Lloyd SK, Evans DG. Neurofibromatosis type 2 (NF2): diagnosis and management. Handbook Clin Neurol. 2013;115:957–967.10.1016/B978-0-444-52902-2.00054-0
   PubMedGoogle Scholar
• Dirks MS, Butman JA, Kim HJ, et al. Long-term natural history of neurofibromatosis type 2-associated intracranial tumors. J Neurosurg. 2012;117:109–117.10.3171/2012.3.JNS111649
   PubMed Web of Science ®Google Scholar
• Karajannis MA, Ferner RE. Neurofibromatosis-related tumors: emerging biology and therapies. Curr Opin Pediatrics. 2015;27:26–33.10.1097/MOP.0000000000000169
   PubMed Web of Science ®Google Scholar
• Maniakas A, Saliba I. Neurofibromatosis type 2 vestibular schwannoma treatment: a review of the literature, trends, and outcomes. Otol Neurotol. 2014;35:889–894.10.1097/MAO.0000000000000272
   PubMed Web of Science ®Google Scholar
• Petrilli AM, Fernandez-Valle C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene. 2016;35:537–548. Epub 2015/04/22.10.1038/onc.2015.125
   PubMed Web of Science ®Google Scholar
• Flaiz C, Chernoff J, Ammoun S, et al. PAK kinase regulates Rac GTPase and is a potential target in human schwannomas. Exp Neurol. 2009;218:137–144.10.1016/j.expneurol.2009.04.019
   PubMed Web of Science ®Google Scholar
• Zhou L, Ercolano E, Ammoun S, et al. Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/beta-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways. Neoplasia. 2011;13:1101–1112. Epub 2012/01/17.10.1593/neo.111060
   PubMed Web of Science ®Google Scholar
• Yi C, Troutman S, Fera D, et al. A tight junction-associated merlin-angiomotin complex mediates Merlin’s regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell. 2011;19:527–540. Epub 2011/04/13.10.1016/j.ccr.2011.02.017
   PubMed Web of Science ®Google Scholar
• Wong HK, Shimizu A, Kirkpatrick ND, et al. Merlin/NF2 regulates angiogenesis in Schwannomas through a Rac1/Semaphorin 3F-dependent mechanism. Neoplasia. 2012;14:84–94.10.1593/neo.111600
   PubMed Web of Science ®Google Scholar
• Nobes CD, Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 1995;81:53–62. Epub 1995/04/07.10.1016/0092-8674(95)90370-4
   PubMed Web of Science ®Google Scholar
• Han J, Weisbrod RM, Shao D, et al. The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: glutathionylation of Rac1 in endothelial cells. Redox Biology. 2016;9:306–319. Epub 2016/10/21.10.1016/j.redox.2016.09.003
   PubMed Web of Science ®Google Scholar
• Chen QY, Xu LQ, Jiao DM, et al. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. Int J Mol Med. 2011;28:769–776. Epub 2011/08/13.
   PubMed Web of Science ®Google Scholar
• Rosenbaum C, Kluwe L, Mautner VF, et al. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis. 1998;5:55–64. Epub 1998/08/14.10.1006/nbdi.1998.0179
   PubMed Web of Science ®Google Scholar
• Benninger Y, Thurnherr T, Pereira JA, et al. Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J Cell Biol. 2007;177:1051–1061. Epub 2007/06/20.10.1083/jcb.200610108
   PubMed Web of Science ®Google Scholar
• Pasten C, Cerda J, Jausoro I, et al. ApoER2 and Reelin are expressed in regenerating peripheral nerve and regulate Schwann cell migration by activating the Rac1 GEF protein, Tiam1. Mol Cell Neurosci. 2015;69:1–11. Epub 2015/09/20.10.1016/j.mcn.2015.09.004
   PubMed Web of Science ®Google Scholar
• Guo L, Moon C, Niehaus K, et al. Rac1 controls Schwann cell myelination through cAMP and NF2/merlin. J Neurosci. 2012;32:17251–17261. Epub 2012/12/01.10.1523/JNEUROSCI.2461-12.2012
   PubMed Web of Science ®Google Scholar
• Manchanda PK, Jones GN, Lee AA, et al. Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors. Oncogene. 2013;32:3491–3499. Epub 2012/10/10.10.1038/onc.2012.374
   PubMed Web of Science ®Google Scholar
• Park HT, Feltri ML. Rac1 GTPase controls myelination and demyelination. BioArchitecture. 2011;1:110–113. Epub 2011/09/17.10.4161/bioa.1.3.16985
   PubMedGoogle Scholar
• Nodari A, Zambroni D, Quattrini A, et al. Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination. J Cell Biol. 2007;177:1063–1075. Epub 2007/06/20.10.1083/jcb.200610014
   PubMed Web of Science ®Google Scholar
• Nguyen LK, Kholodenko BN, von Kriegsheim A. Rac1 and RhoA: networks, loops and bistability. Small GTPases. 2016:1–6. Epub 2016/08/18.10.1080/21541248.2016.1224399
   PubMedGoogle Scholar
• Ye DZ, Jin S, Zhuo Y, et al. p21-Activated kinase 1 (Pak1) phosphorylates BAD directly at serine 111 in vitro and indirectly through Raf-1 at serine 112. PLoS One. 2011;6:e27637. Epub 2011/11/19.10.1371/journal.pone.0027637
   PubMed Web of Science ®Google Scholar
• Ryan MB, Finn AJ, Pedone KH, et al. ERK/MAPK Signaling drives overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-mutant Melanoma. Mol Cancer Res. 2016;14:1009–1018. Epub 2016/07/16.
   Google Scholar
• Barrows D, Schoenfeld SM, Hodakoski C, et al. p21-Activated kinases (PAKs) mediate the phosphorylation of PREX2 protein to initiate feedback inhibition of Rac1 GTPase. J Biol Chem. 2015;290:28915–28931. Epub 2015/10/07.10.1074/jbc.M115.668244
   PubMed Web of Science ®Google Scholar
• Chow HY, Dong B, Duron SG, et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6:1981–1994. Epub 2015/01/19.10.18632/oncotarget.v6i4
   PubMed Web of Science ®Google Scholar